Insight into rheumatological cause and effect through the use of Mendelian randomization

Establishing causality of risk factors is important to determine the pathogenetic mechanisms underlying rheumatic diseases, and can facilitate the design of interventions to improve care for affected patients. The presence of unmeasured confounders, as well as reverse causation, is a challenge to the assignment of causality in observational studies. Alleles for genetic variants are randomly inherited at meiosis. Mendelian randomization analysis uses these genetic variants to test whether a particular risk factor is causal for a disease outcome. In this Review of the Mendelian randomization technique, we discuss published results and potential applications in rheumatology, as well as the general clinical utility and limitations of the approach.

[1]  A. Butterworth,et al.  Mendelian Randomization Analysis With Multiple Genetic Variants Using Summarized Data , 2013, Genetic epidemiology.

[2]  L. See,et al.  Increased risk of cancer among gout patients: a nationwide population study. , 2012, Joint, bone, spine : revue du rhumatisme.

[3]  T. Merriman,et al.  Mendelian randomization analysis associates increased serum urate, due to genetic variation in uric acid transporters, with improved renal function. , 2014, Kidney international.

[4]  Jennifer G. Robinson,et al.  The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis , 2012, The Lancet.

[5]  R. Wright,et al.  Contribution of uric acid to cancer risk, recurrence, and mortality , 2012, Clinical and Translational Medicine.

[6]  M C Hjortland,et al.  High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. , 1977, The American journal of medicine.

[7]  Christian Gieger,et al.  Loci influencing lipid levels and coronary heart disease risk in 16 European population cohorts , 2009, Nature Genetics.

[8]  Fabian J Theis,et al.  Genome-wide association analyses identify 18 new loci associated with serum urate concentrations , 2012, Nature Genetics.

[9]  Abbas Dehghan,et al.  Genome-Wide Association Studies. , 2018, Methods in molecular biology.

[10]  R. Dwek,et al.  Association of rheumatoid arthritis and primary osteoarthritis with changes in the glycosylation pattern of total serum IgG , 1985, Nature.

[11]  O. Mäkitie,et al.  FGF23 gene variation and its association with phosphate homeostasis and bone mineral density in Finnish children and adolescents. , 2015, Bone.

[12]  B. Hollis,et al.  Low circulating vitamin D in obesity , 1988, Calcified Tissue International.

[13]  P. Toth.  LCAT, HDL Cholesterol and Ischemic Cardiovascular Disease: A Mendelian Randomization Study of HDL Cholesterol in 54,500 Individuals , 2012 .

[14]  K. Williams,et al.  Effect of long-term exposure to lower low-density lipoprotein cholesterol beginning early in life on the risk of coronary heart disease: a Mendelian randomization analysis. , 2012, Journal of the American College of Cardiology.

[15]  C. Hayward,et al.  Dataset pertaining to the publication “Loci Associated with N-Glycosylation of Human Immunoglobulin G Show Pleiotropy with Autoimmune Diseases and Haematological Cancers” , 2016 .

[16]  J. Fraumeni,et al.  Leukemia, lymphoma, and multiple myeloma following selected medical conditions , 1992, Cancer Causes & Control.

[17]  Michael Doherty,et al.  The effect of FTO variation on increased osteoarthritis risk is mediated through body mass index: a mendelian randomisation study , 2013, Annals of the rheumatic diseases.

[18]  J. Griffith,et al.  Uric acid and incident kidney disease in the community. , 2008, Journal of the American Society of Nephrology : JASN.

[19]  D. Gurdasani,et al.  The Association Between Circulating Lipoprotein(a) and Type 2 Diabetes: Is It Causal? , 2013, Diabetes.

[20]  E. Krishnan.  Reduced Glomerular Function and Prevalence of Gout: NHANES 2009–10 , 2012, PloS one.

[21]  Meena Kumari,et al.  Separating the Mechanism-Based and Off-Target Actions of Cholesteryl Ester Transfer Protein Inhibitors With CETP Gene Polymorphisms , 2010, Circulation.

[22]  Yan Shi,et al.  The Role of Uric Acid as an Endogenous Danger Signal in Immunity and Inflammation , 2011, Current rheumatology reports.

[23]  D. Kang,et al.  Uric acid and chronic kidney disease: new understanding of an old problem. , 2011, Seminars in nephrology.

[24]  Donal N. Gorman,et al.  Using Multivariable Mendelian Randomization to Disentangle the Causal Effects of Lipid Fractions , 2014, PloS one.

[25]  B. Cowling,et al.  Mendelian randomization and estimation of treatment efficacy for chronic diseases. , 2013, American journal of epidemiology.

[26]  S. Lewis,et al.  Alcohol Intake and Blood Pressure: A Systematic Review Implementing a Mendelian Randomization Approach , 2008, PLoS medicine.

[27]  R. Glynn,et al.  Asymptomatic Hyperuricemia. Risks and Consequences in the Normative Aging Study , 1987 .

[28]  William Weintraub,et al.  Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy. , 2011, The New England journal of medicine.

[29]  T. Merriman,et al.  Lack of gene–diuretic interactions on the risk of incident gout: the Nurses’ Health Study and Health Professionals Follow-up Study , 2015, Annals of the rheumatic diseases.

[30]  Cameron D. Palmer,et al.  Large multiethnic Candidate Gene Study for C-reactive protein levels: identification of a novel association at CD36 in African Americans , 2014, Human Genetics.

[31]  S. Ebrahim,et al.  What can mendelian randomisation tell us about modifiable behavioural and environmental exposures? , 2005, BMJ : British Medical Journal.

[32]  R. Wing,et al.  Human Cardiovascular Disease IBC Chip-Wide Association with Weight Loss and Weight Regain in the Look AHEAD Trial , 2013, Human Heredity.

[33]  J. Danesh,et al.  Causal Assessment of Serum Urate Levels in Cardiometabolic Diseases Through a Mendelian Randomization Study. , 2016, Journal of the American College of Cardiology.

[34]  J. Danesh,et al.  C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis , 2010, The Lancet.

[35]  A. Wolk,et al.  Long term alcohol intake and risk of rheumatoid arthritis in women: a population based cohort study , 2012, BMJ : British Medical Journal.

[36]  P. Boffetta,et al.  A prospective study of gout and cancer , 2009, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[37]  B. Nordestgaard,et al.  Methylenetetrahydrofolate reductase polymorphism (C677T), hyperhomocysteinemia, and risk of ischemic cardiovascular disease and venous thromboembolism: prospective and case-control studies from the Copenhagen City Heart Study. , 2004, Blood.

[38]  M. B. Katan,et al.  Apolipoprotein E isoforms, serum cholesterol, and cancer , 2004 .

[39]  A. Butterworth,et al.  Use of Mendelian randomisation to assess potential benefit of clinical intervention , 2012, BMJ : British Medical Journal.

[40]  T. VanderWeele,et al.  Power and instrument strength requirements for Mendelian randomization studies using multiple genetic variants. , 2011, International journal of epidemiology.

[41]  Markus Abt,et al.  Effects of dalcetrapib in patients with a recent acute coronary syndrome. , 2012, The New England journal of medicine.

[42]  C. Greenwood,et al.  The Causal Effect of Vitamin D Binding Protein (DBP) Levels on Calcemic and Cardiometabolic Diseases: A Mendelian Randomization Study , 2014, PLoS medicine.

[43]  P. Ridker,et al.  Lipoprotein(a) and risk of type 2 diabetes. , 2010, Clinical chemistry.

[44]  Diane J. Berry,et al.  Evaluation of Genetic Markers as Instruments for Mendelian Randomization Studies on Vitamin D , 2012, PloS one.

[45]  R. Luben,et al.  No evidence for a causal link between uric acid and type 2 diabetes: a Mendelian randomisation approach , 2011, Diabetologia.

[46]  M G Marmot,et al.  Alcohol and blood pressure: the INTERSALT study , 1994, BMJ.

[47]  J. Hausman.  Specification tests in econometrics , 1978 .

[48]  M. Goicoechea,et al.  Allopurinol and progression of CKD and cardiovascular events: long-term follow-up of a randomized clinical trial. , 2015, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[49]  R M Aspden,et al.  A COL1A1 Sp1 binding site polymorphism predisposes to osteoporotic fracture by affecting bone density and quality. , 2001, The Journal of clinical investigation.

[50]  M. Tobin,et al.  Meta‐analysis of Mendelian randomization studies incorporating all three genotypes , 2008, Statistics in medicine.

[51]  A. Butterworth,et al.  Network Mendelian randomization: using genetic variants as instrumental variables to investigate mediation in causal pathways , 2014, International journal of epidemiology.

[52]  J. Tschopp,et al.  Activation of the NLRP3 inflammasome in dendritic cells induces IL-1β–dependent adaptive immunity against tumors , 2009, Nature Medicine.

[53]  R. Jorde,et al.  Supplementation with cholecalciferol does not result in weight reduction in overweight and obese subjects. , 2008, European journal of endocrinology.

[54]  G. Pearlson,et al.  Serum uric acid and cognitive function in community-dwelling older adults. , 2007, Neuropsychology.

[55]  B. Gersh.  Safety of Anacetrapib in Patients with or at High Risk for Coronary Heart Disease , 2011 .

[56]  A. Reunanen,et al.  Raised serum urate concentration as risk factor for premature mortality in middle aged men. , 1984, British medical journal.

[57]  T. Merriman,et al.  Causal or Noncausal Relationship of Uric Acid With Diabetes , 2015, Diabetes.

[58]  S. Ring,et al.  Prenatal alcohol exposure and offspring cognition and school performance. A ‘Mendelian randomization’ natural experiment , 2013, International journal of epidemiology.

[59]  K. Brownell,et al.  Effects of soft drink consumption on nutrition and health: a systematic review and meta-analysis. , 2007, American journal of public health.

[60]  R. Moore,et al.  Alcohol consumption and blood pressure in the 1982 Maryland Hypertension Survey. , 1990, American journal of hypertension.

[61]  A. Barton,et al.  Testing the role of vitamin D in response to antitumour necrosis factor α therapy in a UK cohort: a Mendelian randomisation approach , 2013, Annals of the rheumatic diseases.

[62]  B. Ames,et al.  Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[63]  E. Trell,et al.  Raised serum urate concentration as risk factor for premature mortality in middle aged men: relation to death from cancer. , 1983, British medical journal.

[64]  Uwe Völker,et al.  New loci associated with kidney function and chronic kidney disease , 2010, Nature Genetics.

[65]  Tom R. Gaunt,et al.  Loci influencing blood pressure identified using a cardiovascular gene-centric array. , 2013, Human molecular genetics.

[66]  J. Singh,et al.  Risk factors for gout and prevention: a systematic review of the literature , 2011, Current opinion in rheumatology.

[67]  R. Glynn,et al.  Asymptomatic hyperuricemia. Risks and consequences in the Normative Aging Study. , 1987, The American journal of medicine.

[68]  George Davey Smith,et al.  Mendelian randomization: Using genes as instruments for making causal inferences in epidemiology , 2008, Statistics in medicine.

[69]  L. Chambless,et al.  Alcohol Consumption and the Incidence of Hypertension: The Atherosclerosis Risk in Communities Study , 2001, Hypertension.

[70]  Christopher F. Baum,et al.  Instrumental Variables and GMM: Estimation and Testing , 2003 .

[71]  Tom R. Gaunt,et al.  Plasma urate concentration and risk of coronary heart disease: a Mendelian randomisation analysis , 2016, The lancet. Diabetes & endocrinology.

[72]  K. Channon,et al.  Statins as Anti-Inflammatory Agents in Atherogenesis: Molecular Mechanisms and Lessons from the Recent Clinical Trials , 2012, Current pharmaceutical design.

[73]  S. Thompson,et al.  Avoiding bias from weak instruments in Mendelian randomization studies. , 2011, International journal of epidemiology.

[74]  S. Burgess.  Sample size and power calculations in Mendelian randomization with a single instrumental variable and a binary outcome , 2014, International journal of epidemiology.

[75]  Eric J Tchetgen Tchetgen,et al.  Methodological Challenges in Mendelian Randomization , 2014, Epidemiology.

[76]  T. Merriman,et al.  Mendelian Randomization Provides No Evidence for a Causal Role of Serum Urate in Increasing Serum Triglyceride Levels , 2014, Circulation. Cardiovascular genetics.

[77]  Tom M Palmer,et al.  Association of plasma uric acid with ischaemic heart disease and blood pressure: mendelian randomisation analysis of two large cohorts , 2013, BMJ.

[78]  J. Coresh,et al.  A urate gene-by-diuretic interaction and gout risk in participants with hypertension: results from the ARIC study , 2012, Annals of the rheumatic diseases.

[79]  John Spertus,et al.  Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study , 2012, The Lancet.

[80]  P. Mueller,et al.  Homocyst(e)ine and cardiovascular disease: a systematic review of the evidence with special emphasis on case-control studies and nested case-control studies. , 2002, International journal of epidemiology.

[81]  J. McGeary,et al.  Shared additive genetic influences on DSM-IV criteria for alcohol dependence in subjects of European ancestry. , 2015, Addiction.

[82]  George Davey Smith.  Association between C reactive protein and coronary heart disease: mendelian randomisation analysis based on individual participant data , 2011 .

[83]  T. Lehtimäki,et al.  Associations between serum uric acid and markers of subclinical atherosclerosis in young adults. The cardiovascular risk in Young Finns study. , 2012, Atherosclerosis.

[84]  Petra Verhoef,et al.  MTHFR 677C-->T polymorphism and risk of coronary heart disease: a meta-analysis. , 2002, JAMA.

[85]  T. Merriman,et al.  Sugar-sweetened beverage consumption: a risk factor for prevalent gout with SLC2A9 genotype-specific effects on serum urate and risk of gout , 2013, Annals of the rheumatic diseases.

[86]  Hyon K. Choi,et al.  Sugar-sweetened soft drinks, diet soft drinks, and serum uric acid level: the Third National Health and Nutrition Examination Survey. , 2008, Arthritis and rheumatism.

[87]  D. Lawlor,et al.  The detection, treatment and control of high blood pressure in older British adults: cross-sectional findings from the British Women's Heart and Health Study and the British Regional Heart Study , 2006, Journal of Human Hypertension.

[88]  David M. Evans,et al.  Mendelian Randomization: New Applications in the Coming Age of Hypothesis-Free Causality. , 2015, Annual review of genomics and human genetics.

[89]  George Davey Smith,et al.  Using multiple genetic variants as instrumental variables for modifiable risk factors , 2012, Statistical methods in medical research.

[90]  A. V. Rij,et al.  Twenty-eight loci that influence serum urate levels: analysis of association with gout , 2014, Annals of the rheumatic diseases.

[91]  R. Hiatt,et al.  Serum uric acid unrelated to cancer incidence in humans. , 1988, Cancer research.

[92]  Christian Gieger,et al.  New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk , 2010, Nature Genetics.

[93]  A. Barton,et al.  The role of genetic polymorphisms regulating vitamin D levels in rheumatoid arthritis outcome: a Mendelian randomisation approach , 2014, Annals of the rheumatic diseases.

[94]  K. Michaud,et al.  Weight Loss, the Obesity Paradox, and the Risk of Death in Rheumatoid Arthritis , 2015, Arthritis & rheumatology.

[95]  C. Bower,et al.  Guidelines for pregnancy: what's an acceptable risk, and how is the evidence (finally) shaping up? , 2012, Drug and alcohol review.

[96]  Stephen Burgess,et al.  Combining information on multiple instrumental variables in Mendelian randomization: comparison of allele score and summarized data methods , 2015, Statistics in medicine.

[97]  H. Koprowski,et al.  Uric acid levels in patients with multiple sclerosis: analysis in mono- and dizygotic twins , 2001, Multiple sclerosis.

[98]  R. Koerfer,et al.  Vitamin D supplementation enhances the beneficial effects of weight loss on cardiovascular disease risk markers. , 2009, The American journal of clinical nutrition.

[99]  M. Rieder,et al.  Common Missense Variant in the Glucokinase Regulatory Protein Gene Is Associated With Increased Plasma Triglyceride and C-Reactive Protein but Lower Fasting Glucose Concentrations , 2008, Diabetes.

[100]  V. Rousson,et al.  Serum Uric Acid and Adiposity: Deciphering Causality Using a Bidirectional Mendelian Randomization Approach , 2012, PloS one.

[101]  P. Gregersen,et al.  Loci associated with N-glycosylation of human IgG are not associated with rheumatoid arthritis: a Mendelian randomisation study , 2015, Annals of the rheumatic diseases.

[102]  C. O’Donnell,et al.  Mendelian randomization: nature's randomized trial in the post-genome era. , 2009, JAMA.

[103]  D. van der A,et al.  A Mendelian Randomization Study of Circulating Uric Acid and Type 2 Diabetes , 2015, Diabetes.

[104]  S. Ebrahim,et al.  'Mendelian randomization': can genetic epidemiology contribute to understanding environmental determinants of disease? , 2003, International journal of epidemiology.

[105]  M. Caulfield,et al.  Effects of torcetrapib in patients at high risk for coronary events , 2008 .

[106]  M. Calvo,et al.  The effects of high phosphorus intake on calcium homeostasis. , 1994, Advances in nutritional research.

[107]  F. Shidfar,et al.  Vitamin D3 and the risk of CVD in overweight and obese women: a randomised controlled trial. , 2012, The British journal of nutrition.

[108]  T. Spector,et al.  Causal Relationship between Obesity and Vitamin D Status: Bi-Directional Mendelian Randomization Analysis of Multiple Cohorts , 2013, PLoS medicine.

[109]  L. Kolonel,et al.  Relationship of serum uric acid to cancer occurrence in a prospective male cohort. , 1994, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[110]  Richard J. Johnson,et al.  Uric Acid: The Oxidant-Antioxidant Paradox , 2008, Nucleosides, nucleotides & nucleic acids.

[111]  A. Dyer,et al.  Serum uric acid and 11.5-year mortality of middle-aged women: findings of the Chicago Heart Association Detection Project in Industry. , 1989, Journal of clinical epidemiology.

[112]  Manuel A. R. Ferreira,et al.  Cardiometabolic effects of genetic upregulation of the interleukin 1 receptor antagonist: a Mendelian randomisation analysis , 2015, The lancet. Diabetes & endocrinology.

[113]  A. Hofman,et al.  Serum uric acid and cognitive function and dementia. , 2008, Brain : a journal of neurology.

[114]  A. Wolk,et al.  Cigarette smoking and risk of rheumatoid arthritis: a dose-response meta-analysis , 2014, Arthritis Research & Therapy.

[115]  Saskia le Cessie,et al.  Mendelian randomization studies: a review of the approaches used and the quality of reporting. , 2015, International journal of epidemiology.

[116]  T. Merriman.  An update on the genetic architecture of hyperuricemia and gout , 2015, Arthritis Research & Therapy.